 | • レポートコード：QAF27016 • 出版社/出版日：QYResearch / 2021年4月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（即日納品） • 産業分類：医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の乳がん検診市場について種類別（マンモグラフィ検診、乳房磁気共鳴画像法（MRI）検診、乳房超音波検診）、用途別（病院、クリニック）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・乳がん検診市場の概要 ・世界の主要地域別乳がん検診市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の乳がん検診市場規模2016-2021：種類別（マンモグラフィ検診、乳房磁気共鳴画像法（MRI）検診、乳房超音波検診） ・世界の乳がん検診市場予測2012-2027：種類別（マンモグラフィ検診、乳房磁気共鳴画像法（MRI）検診、乳房超音波検診） ・世界の乳がん検診市場規模2016-2021：用途別（病院、クリニック） ・世界の乳がん検診市場予測2012-2027：用途別（病院、クリニック） ・乳がん検診のアメリカ市場規模と予測2016-2021 ・乳がん検診のヨーロッパ市場規模と予測2016-2021 ・乳がん検診の中国市場規模と予測2016-2021 ・乳がん検診の日本市場規模と予測2016-2021 ・乳がん検診の東南アジア市場規模と予測2016-2021 ・乳がん検診のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Hologic、GE Healthcare、Siemen Healthineers、Philips Healthcare、Canon Medical、Fujifilm、Metaltronica、Sino Medical-Device、IMS Srl） ・乳がん検診の製造コスト分析 ・販売チャネル、流通業者、顧客 ・乳がん検診の市場動向・機会・課題 ・調査の結論 |
Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.
Major players in the market are identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, Market Share (%)s, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
Market Analysis and Insights: Global Breast Cancer Screening Market
The global Breast Cancer Screening market was valued at US$ 1983.7 in 2020 and will reach US$ 3218.5 million by the end of 2027, growing at a CAGR of 8.4% during 2022-2027.
Global Breast Cancer Screening Scope and Market Size
The global Breast Cancer Screening market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Mammography Screening
Breast Magnetic Resonance Imaging (MRI) Screening
Breast Ultrasound Screening
Segment by Application
Hospital
Clinic
The Breast Cancer Screening market is analysed and market size information is provided by regions (countries). Segment by Application, the Breast Cancer Screening market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Hologic
GE Healthcare
Siemen Healthineers
Philips Healthcare
Canon Medical
Fujifilm
Metaltronica
Sino Medical-Device
IMS Srl
1 Breast Cancer Screening Market Overview
1.1 Breast Cancer Screening Product Scope
1.2 Breast Cancer Screening Segment by Type
1.2.1 Global Breast Cancer Screening Sales by Type (2016 & 2021 & 2027)
1.2.2 Mammography Screening
1.2.3 Breast Magnetic Resonance Imaging (MRI) Screening
1.2.4 Breast Ultrasound Screening
1.3 Breast Cancer Screening Segment by Application
1.3.1 Global Breast Cancer Screening Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.4 Breast Cancer Screening Market Estimates and Forecasts (2016-2027)
1.4.1 Global Breast Cancer Screening Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Breast Cancer Screening Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Breast Cancer Screening Price Trends (2016-2027)
2 Breast Cancer Screening Estimates and Forecasts by Region
2.1 Global Breast Cancer Screening Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Breast Cancer Screening Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Breast Cancer Screening Sales Market Share by Region (2016-2021)
2.2.2 Global Breast Cancer Screening Revenue Market Share by Region (2016-2021)
2.3 Global Breast Cancer Screening Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Breast Cancer Screening Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Breast Cancer Screening Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Breast Cancer Screening Estimates and Projections (2016-2027)
2.4.2 Europe Breast Cancer Screening Estimates and Projections (2016-2027)
2.4.3 China Breast Cancer Screening Estimates and Projections (2016-2027)
2.4.4 Japan Breast Cancer Screening Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Breast Cancer Screening Estimates and Projections (2016-2027)
2.4.6 India Breast Cancer Screening Estimates and Projections (2016-2027)
3 Global Breast Cancer Screening Competition Landscape by Players
3.1 Global Top Breast Cancer Screening Players by Sales (2016-2021)
3.2 Global Top Breast Cancer Screening Players by Revenue (2016-2021)
3.3 Global Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Breast Cancer Screening as of 2020)
3.4 Global Breast Cancer Screening Average Price by Company (2016-2021)
3.5 Manufacturers Breast Cancer Screening Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Breast Cancer Screening Market Size by Type
4.1 Global Breast Cancer Screening Historic Market Review by Type (2016-2021)
4.1.1 Global Breast Cancer Screening Sales Market Share by Type (2016-2021)
4.1.2 Global Breast Cancer Screening Revenue Market Share by Type (2016-2021)
4.1.3 Global Breast Cancer Screening Price by Type (2016-2021)
4.2 Global Breast Cancer Screening Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Breast Cancer Screening Sales Forecast by Type (2022-2027)
4.2.2 Global Breast Cancer Screening Revenue Forecast by Type (2022-2027)
4.2.3 Global Breast Cancer Screening Price Forecast by Type (2022-2027)
5 Global Breast Cancer Screening Market Size by Application
5.1 Global Breast Cancer Screening Historic Market Review by Application (2016-2021)
5.1.1 Global Breast Cancer Screening Sales Market Share by Application (2016-2021)
5.1.2 Global Breast Cancer Screening Revenue Market Share by Application (2016-2021)
5.1.3 Global Breast Cancer Screening Price by Application (2016-2021)
5.2 Global Breast Cancer Screening Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Breast Cancer Screening Sales Forecast by Application (2022-2027)
5.2.2 Global Breast Cancer Screening Revenue Forecast by Application (2022-2027)
5.2.3 Global Breast Cancer Screening Price Forecast by Application (2022-2027)
6 North America Breast Cancer Screening Market Facts & Figures
6.1 North America Breast Cancer Screening Sales by Company
6.1.1 North America Breast Cancer Screening Sales by Company (2016-2021)
6.1.2 North America Breast Cancer Screening Revenue by Company (2016-2021)
6.2 North America Breast Cancer Screening Sales Breakdown by Type
6.2.1 North America Breast Cancer Screening Sales Breakdown by Type (2016-2021)
6.2.2 North America Breast Cancer Screening Sales Breakdown by Type (2022-2027)
6.3 North America Breast Cancer Screening Sales Breakdown by Application
6.3.1 North America Breast Cancer Screening Sales Breakdown by Application (2016-2021)
6.3.2 North America Breast Cancer Screening Sales Breakdown by Application (2022-2027)
7 Europe Breast Cancer Screening Market Facts & Figures
7.1 Europe Breast Cancer Screening Sales by Company
7.1.1 Europe Breast Cancer Screening Sales by Company (2016-2021)
7.1.2 Europe Breast Cancer Screening Revenue by Company (2016-2021)
7.2 Europe Breast Cancer Screening Sales Breakdown by Type
7.2.1 Europe Breast Cancer Screening Sales Breakdown by Type (2016-2021)
7.2.2 Europe Breast Cancer Screening Sales Breakdown by Type (2022-2027)
7.3 Europe Breast Cancer Screening Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)
8 China Breast Cancer Screening Market Facts & Figures
8.1 China Breast Cancer Screening Sales by Company
8.1.1 China Breast Cancer Screening Sales by Company (2016-2021)
8.1.2 China Breast Cancer Screening Revenue by Company (2016-2021)
8.2 China Breast Cancer Screening Sales Breakdown by Type
8.2.1 China Breast Cancer Screening Sales Breakdown by Type (2016-2021)
8.2.2 China Breast Cancer Screening Sales Breakdown by Type (2022-2027)
8.3 China Breast Cancer Screening Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Breast Cancer Screening Market Facts & Figures
9.1 Japan Breast Cancer Screening Sales by Company
9.1.1 Japan Breast Cancer Screening Sales by Company (2016-2021)
9.1.2 Japan Breast Cancer Screening Revenue by Company (2016-2021)
9.2 Japan Breast Cancer Screening Sales Breakdown by Type
9.2.1 Japan Breast Cancer Screening Sales Breakdown by Type (2016-2021)
9.2.2 Japan Breast Cancer Screening Sales Breakdown by Type (2022-2027)
9.3 Japan Breast Cancer Screening Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Breast Cancer Screening Market Facts & Figures
10.1 Southeast Asia Breast Cancer Screening Sales by Company
10.1.1 Southeast Asia Breast Cancer Screening Sales by Company (2016-2021)
10.1.2 Southeast Asia Breast Cancer Screening Revenue by Company (2016-2021)
10.2 Southeast Asia Breast Cancer Screening Sales Breakdown by Type
10.2.1 Southeast Asia Breast Cancer Screening Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Breast Cancer Screening Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Breast Cancer Screening Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Breast Cancer Screening Market Facts & Figures
11.1 India Breast Cancer Screening Sales by Company
11.1.1 India Breast Cancer Screening Sales by Company (2016-2021)
11.1.2 India Breast Cancer Screening Revenue by Company (2016-2021)
11.2 India Breast Cancer Screening Sales Breakdown by Type
11.2.1 India Breast Cancer Screening Sales Breakdown by Type (2016-2021)
11.2.2 India Breast Cancer Screening Sales Breakdown by Type (2022-2027)
11.3 India Breast Cancer Screening Sales Breakdown by Application
11.3.1 India Breast Cancer Screening Sales Breakdown by Application (2016-2021)
11.3.2 India Breast Cancer Screening Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Breast Cancer Screening Business
12.1 Hologic
12.1.1 Hologic Corporation Information
12.1.2 Hologic Business Overview
12.1.3 Hologic Breast Cancer Screening Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Hologic Breast Cancer Screening Products Offered
12.1.5 Hologic Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Corporation Information
12.2.2 GE Healthcare Business Overview
12.2.3 GE Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GE Healthcare Breast Cancer Screening Products Offered
12.2.5 GE Healthcare Recent Development
12.3 Siemen Healthineers
12.3.1 Siemen Healthineers Corporation Information
12.3.2 Siemen Healthineers Business Overview
12.3.3 Siemen Healthineers Breast Cancer Screening Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Siemen Healthineers Breast Cancer Screening Products Offered
12.3.5 Siemen Healthineers Recent Development
12.4 Philips Healthcare
12.4.1 Philips Healthcare Corporation Information
12.4.2 Philips Healthcare Business Overview
12.4.3 Philips Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Philips Healthcare Breast Cancer Screening Products Offered
12.4.5 Philips Healthcare Recent Development
12.5 Canon Medical
12.5.1 Canon Medical Corporation Information
12.5.2 Canon Medical Business Overview
12.5.3 Canon Medical Breast Cancer Screening Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Canon Medical Breast Cancer Screening Products Offered
12.5.5 Canon Medical Recent Development
12.6 Fujifilm
12.6.1 Fujifilm Corporation Information
12.6.2 Fujifilm Business Overview
12.6.3 Fujifilm Breast Cancer Screening Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fujifilm Breast Cancer Screening Products Offered
12.6.5 Fujifilm Recent Development
12.7 Metaltronica
12.7.1 Metaltronica Corporation Information
12.7.2 Metaltronica Business Overview
12.7.3 Metaltronica Breast Cancer Screening Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Metaltronica Breast Cancer Screening Products Offered
12.7.5 Metaltronica Recent Development
12.8 Sino Medical-Device
12.8.1 Sino Medical-Device Corporation Information
12.8.2 Sino Medical-Device Business Overview
12.8.3 Sino Medical-Device Breast Cancer Screening Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sino Medical-Device Breast Cancer Screening Products Offered
12.8.5 Sino Medical-Device Recent Development
12.9 IMS Srl
12.9.1 IMS Srl Corporation Information
12.9.2 IMS Srl Business Overview
12.9.3 IMS Srl Breast Cancer Screening Sales, Revenue and Gross Margin (2016-2021)
12.9.4 IMS Srl Breast Cancer Screening Products Offered
12.9.5 IMS Srl Recent Development
13 Breast Cancer Screening Manufacturing Cost Analysis
13.1 Breast Cancer Screening Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Breast Cancer Screening
13.4 Breast Cancer Screening Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Breast Cancer Screening Distributors List
14.3 Breast Cancer Screening Customers
15 Market Dynamics
15.1 Breast Cancer Screening Market Trends
15.2 Breast Cancer Screening Drivers
15.3 Breast Cancer Screening Market Challenges
15.4 Breast Cancer Screening Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Breast Cancer Screening Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Breast Cancer Screening Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Breast Cancer Screening Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Breast Cancer Screening Sales (K Units) by Region (2016-2021)
Table 5. Global Breast Cancer Screening Sales Market Share by Region (2016-2021)
Table 6. Global Breast Cancer Screening Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Breast Cancer Screening Revenue Share by Region (2016-2021)
Table 8. Global Breast Cancer Screening Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Breast Cancer Screening Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Breast Cancer Screening Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Breast Cancer Screening Revenue Share Forecast by Region (2022-2027)
Table 12. Global Breast Cancer Screening Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Breast Cancer Screening Sales Share by Company (2016-2021)
Table 14. Global Breast Cancer Screening Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Breast Cancer Screening Revenue Share by Company (2016-2021)
Table 16. Global Breast Cancer Screening by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Screening as of 2020)
Table 17. Global Breast Cancer Screening Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Breast Cancer Screening Manufacturing Sites and Area Served
Table 19. Manufacturers Breast Cancer Screening Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Breast Cancer Screening Sales (K Units) by Type (2016-2021)
Table 22. Global Breast Cancer Screening Sales Share by Type (2016-2021)
Table 23. Global Breast Cancer Screening Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Breast Cancer Screening Price (USD/Unit) by Type (2016-2021)
Table 25. Global Breast Cancer Screening Sales Share by Type (2022-2027)
Table 26. Global Breast Cancer Screening Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Breast Cancer Screening Revenue Share by Type (2022-2027)
Table 28. Global Breast Cancer Screening Price (USD/Unit) by Type (2022-2027)
Table 29. Global Breast Cancer Screening Sales (K Units) by Application (2016-2021)
Table 30. Global Breast Cancer Screening Sales Share by Application (2016-2021)
Table 31. Global Breast Cancer Screening Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Breast Cancer Screening Price (USD/Unit) by Application (2016-2021)
Table 33. Global Breast Cancer Screening Sales (K Units) by Application (2022-2027)
Table 34. Global Breast Cancer Screening Sales Share by Application (2022-2027)
Table 35. Global Breast Cancer Screening Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Breast Cancer Screening Revenue Share by Application (2022-2027)
Table 37. Global Breast Cancer Screening Price (USD/Unit) by Application (2022-2027)
Table 38. North America Breast Cancer Screening Sales (K Units) by Company (2016-2021)
Table 39. North America Breast Cancer Screening Sales Market Share by Company (2016-2021)
Table 40. North America Breast Cancer Screening Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Breast Cancer Screening Revenue Market Share by Company (2016-2021)
Table 42. North America Breast Cancer Screening Sales by Type (2016-2021) & (K Units)
Table 43. North America Breast Cancer Screening Sales Market Share by Type (2016-2021)
Table 44. North America Breast Cancer Screening Sales by Type (2022-2027) & (K Units)
Table 45. North America Breast Cancer Screening Sales Market Share by Type (2022-2027)
Table 46. North America Breast Cancer Screening Sales by Application (2016-2021) & (K Units)
Table 47. North America Breast Cancer Screening Sales Market Share by Application (2016-2021)
Table 48. North America Breast Cancer Screening Sales by Application (2022-2027) & (K Units)
Table 49. North America Breast Cancer Screening Sales Market Share by Application (2022-2027)
Table 50. Europe Breast Cancer Screening Sales (K Units) by Company (2016-2021)
Table 51. Europe Breast Cancer Screening Sales Market Share by Company (2016-2021)
Table 52. Europe Breast Cancer Screening Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Breast Cancer Screening Revenue Market Share by Company (2016-2021)
Table 54. Europe Breast Cancer Screening Sales by Type (2016-2021) & (K Units)
Table 55. Europe Breast Cancer Screening Sales Market Share by Type (2016-2021)
Table 56. Europe Breast Cancer Screening Sales by Type (2022-2027) & (K Units)
Table 57. Europe Breast Cancer Screening Sales Market Share by Type (2022-2027)
Table 58. Europe Breast Cancer Screening Sales by Application (2016-2021) & (K Units)
Table 59. Europe Breast Cancer Screening Sales Market Share by Application (2016-2021)
Table 60. Europe Breast Cancer Screening Sales by Application (2022-2027) & (K Units)
Table 61. Europe Breast Cancer Screening Sales Market Share by Application (2022-2027)
Table 62. China Breast Cancer Screening Sales (K Units) by Company (2016-2021)
Table 63. China Breast Cancer Screening Sales Market Share by Company (2016-2021)
Table 64. China Breast Cancer Screening Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Breast Cancer Screening Revenue Market Share by Company (2016-2021)
Table 66. China Breast Cancer Screening Sales by Type (2016-2021) & (K Units)
Table 67. China Breast Cancer Screening Sales Market Share by Type (2016-2021)
Table 68. China Breast Cancer Screening Sales by Type (2022-2027) & (K Units)
Table 69. China Breast Cancer Screening Sales Market Share by Type (2022-2027)
Table 70. China Breast Cancer Screening Sales by Application (2016-2021) & (K Units)
Table 71. China Breast Cancer Screening Sales Market Share by Application (2016-2021)
Table 72. China Breast Cancer Screening Sales by Application (2022-2027) & (K Units)
Table 73. China Breast Cancer Screening Sales Market Share by Application (2022-2027)
Table 74. Japan Breast Cancer Screening Sales (K Units) by Company (2016-2021)
Table 75. Japan Breast Cancer Screening Sales Market Share by Company (2016-2021)
Table 76. Japan Breast Cancer Screening Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Breast Cancer Screening Revenue Market Share by Company (2016-2021)
Table 78. Japan Breast Cancer Screening Sales by Type (2016-2021) & (K Units)
Table 79. Japan Breast Cancer Screening Sales Market Share by Type (2016-2021)
Table 80. Japan Breast Cancer Screening Sales by Type (2022-2027) & (K Units)
Table 81. Japan Breast Cancer Screening Sales Market Share by Type (2022-2027)
Table 82. Japan Breast Cancer Screening Sales by Application (2016-2021) & (K Units)
Table 83. Japan Breast Cancer Screening Sales Market Share by Application (2016-2021)
Table 84. Japan Breast Cancer Screening Sales by Application (2022-2027) & (K Units)
Table 85. Japan Breast Cancer Screening Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Breast Cancer Screening Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Breast Cancer Screening Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Breast Cancer Screening Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Breast Cancer Screening Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Breast Cancer Screening Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Breast Cancer Screening Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Breast Cancer Screening Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Breast Cancer Screening Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Breast Cancer Screening Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Breast Cancer Screening Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Breast Cancer Screening Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Breast Cancer Screening Sales Market Share by Application (2022-2027)
Table 98. India Breast Cancer Screening Sales (K Units) by Company (2016-2021)
Table 99. India Breast Cancer Screening Sales Market Share by Company (2016-2021)
Table 100. India Breast Cancer Screening Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Breast Cancer Screening Revenue Market Share by Company (2016-2021)
Table 102. India Breast Cancer Screening Sales by Type (2016-2021) & (K Units)
Table 103. India Breast Cancer Screening Sales Market Share by Type (2016-2021)
Table 104. India Breast Cancer Screening Sales by Type (2022-2027) & (K Units)
Table 105. India Breast Cancer Screening Sales Market Share by Type (2022-2027)
Table 106. India Breast Cancer Screening Sales by Application (2016-2021) & (K Units)
Table 107. India Breast Cancer Screening Sales Market Share by Application (2016-2021)
Table 108. India Breast Cancer Screening Sales by Application (2022-2027) & (K Units)
Table 109. India Breast Cancer Screening Sales Market Share by Application (2022-2027)
Table 110. Hologic Corporation Information
Table 111. Hologic Description and Business Overview
Table 112. Hologic Breast Cancer Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Hologic Breast Cancer Screening Product
Table 114. Hologic Recent Development
Table 115. GE Healthcare Corporation Information
Table 116. GE Healthcare Description and Business Overview
Table 117. GE Healthcare Breast Cancer Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. GE Healthcare Breast Cancer Screening Product
Table 119. GE Healthcare Recent Development
Table 120. Siemen Healthineers Corporation Information
Table 121. Siemen Healthineers Description and Business Overview
Table 122. Siemen Healthineers Breast Cancer Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Siemen Healthineers Breast Cancer Screening Product
Table 124. Siemen Healthineers Recent Development
Table 125. Philips Healthcare Corporation Information
Table 126. Philips Healthcare Description and Business Overview
Table 127. Philips Healthcare Breast Cancer Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Philips Healthcare Breast Cancer Screening Product
Table 129. Philips Healthcare Recent Development
Table 130. Canon Medical Corporation Information
Table 131. Canon Medical Description and Business Overview
Table 132. Canon Medical Breast Cancer Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Canon Medical Breast Cancer Screening Product
Table 134. Canon Medical Recent Development
Table 135. Fujifilm Corporation Information
Table 136. Fujifilm Description and Business Overview
Table 137. Fujifilm Breast Cancer Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Fujifilm Breast Cancer Screening Product
Table 139. Fujifilm Recent Development
Table 140. Metaltronica Corporation Information
Table 141. Metaltronica Description and Business Overview
Table 142. Metaltronica Breast Cancer Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Metaltronica Breast Cancer Screening Product
Table 144. Metaltronica Recent Development
Table 145. Sino Medical-Device Corporation Information
Table 146. Sino Medical-Device Breast Cancer Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Sino Medical-Device Description and Business Overview
Table 148. Sino Medical-Device Breast Cancer Screening Product
Table 149. Sino Medical-Device Recent Development
Table 150. IMS Srl Corporation Information
Table 151. IMS Srl Breast Cancer Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. IMS Srl Description and Business Overview
Table 153. IMS Srl Breast Cancer Screening Product
Table 154. IMS Srl Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Breast Cancer Screening Distributors List
Table 158. Breast Cancer Screening Customers List
Table 159. Breast Cancer Screening Market Trends
Table 160. Breast Cancer Screening Market Drivers
Table 161. Breast Cancer Screening Market Challenges
Table 162. Breast Cancer Screening Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Breast Cancer Screening Product Picture
Figure 2. Global Breast Cancer Screening Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Breast Cancer Screening Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Global Breast Cancer Screening Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Breast Cancer Screening Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Breast Cancer Screening Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Breast Cancer Screening Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Breast Cancer Screening Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Breast Cancer Screening Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Breast Cancer Screening Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Breast Cancer Screening Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Breast Cancer Screening Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Breast Cancer Screening Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Breast Cancer Screening Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Breast Cancer Screening Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Breast Cancer Screening Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Breast Cancer Screening Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Breast Cancer Screening Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Breast Cancer Screening Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Breast Cancer Screening Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Breast Cancer Screening Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Breast Cancer Screening Players Market Share by Revenue in Breast Cancer Screening: 2016 & 2020
Figure 27. Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Breast Cancer Screening Revenue Share by Type (2016-2021)
Figure 29. Global Breast Cancer Screening Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Breast Cancer Screening Revenue Share by Application (2016-2021)
Figure 31. Global Breast Cancer Screening Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Breast Cancer Screening Sales Market Share by Type in 2020
Figure 33. North America Breast Cancer Screening Sales Market Share by Application in 2020
Figure 34. Europe Breast Cancer Screening Sales Market Share by Type in 2020
Figure 35. Europe Breast Cancer Screening Sales Market Share by Application in 2020
Figure 36. China Breast Cancer Screening Sales Market Share by Type in 2020
Figure 37. China Breast Cancer Screening Sales Market Share by Application in 2020
Figure 38. Japan Breast Cancer Screening Sales Market Share by Type in 2020
Figure 39. Japan Breast Cancer Screening Sales Market Share by Application in 2020
Figure 40. Southeast Asia Breast Cancer Screening Sales Market Share by Type in 2020
Figure 41. Southeast Asia Breast Cancer Screening Sales Market Share by Application in 2020
Figure 42. India Breast Cancer Screening Sales Market Share by Type in 2020
Figure 43. India Breast Cancer Screening Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Breast Cancer Screening
Figure 46. Manufacturing Process Analysis of Breast Cancer Screening
Figure 47. Breast Cancer Screening Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界の乳がん検査市場規模・現状・予測（2021年-2027年） Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, di…- 世界の乳がん分子病理学診断市場規模・現状・予測（2021年-2027年） A molecular approach for women to diagnose breast cancer Market Analysis and Insights: Global Breast Cancer Molecular Diagnostics Market The global Breast Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-…
- 乳がん検査のグローバル市場：規模・現状・予測2019-2025 Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, di…
- 乳がん検査のグローバル市場：規模・現状・予測2019-2025 Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, di…
- 世界の乳がん診断市場規模・現状・予測（2021年-2027年） Breast cancer can be diagnosed through multiple tests, including a mammogram, ultrasound, MRI and biopsy. Market Analysis and Insights: Global Breast Cancer Diagnostic Market The global Breast Cancer Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…